Here, our integrative analysis of multiple cell line models and tRCC tumors converges on metabolic reprogramming towards OXPHOS as a shared and critical oncogenic function of TFE3 fusions. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.